About this trial
The goal of this implementation study is to improve aftercare for patients with ABI receiving outpatient rehabilitation. The ABI-motion program was developed to improve and active lifestyle and to prevent persistent complaints after ABI and poor HR-QoL.The main questions it aims to answer are:
* Is the ABI-motion program feasible? * What are the health benefits of the ABI-motion program?
Participants will receive brain education, a joint therapy session with a physical or occupational or movement therapist and a buddy from a patient support organization during outpatient rehabilitation, followed by community buddy support after discharge from outpatient rehabilitation, and follow-up by a rehabilitation physician.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Diagnosed with ABI
Follows an outpatient rehabilitation program for ABI in Rijndam Rehabilitation
Disqualifiers
Having a contra-indication for participation in moderate to vigorous exercise
Life expectancy < 1 year
Incapacitated persons
Trial design
Sequential
Treatments tested in this trial
ABI-motion program
BehavioralThe ABI-motion program strengthens the cooperation between outpatient rehabilitation professionals and community care providers.
Treatment groups
Trial outcomes
Primary outcomes
Difference in proportion of patients participating in buddy support programs after rehabilitation discharge
Proportion of patients in the ABI-motion group that continues community buddy support after rehabilitation discharge compared with standard care
Mean rating of satisfaction with the ABI-motion program
Satisfaction with the ABI-motion program is rated on a rating scale, ranging from 0 (worst) to 10 (best).
Secondary outcomes
Change in total minutes of physical activity/week at 6 and 12 months compared with controls
Physical activity is measured with an activity monitor (min/week) and electronic diary
Change in Montreal Cognitive Assessment (MoCA) score at 6 and 12 months compared with controls.
The MoCA is a screening tool for detection of mild cognitive impairment. The total score ranges from 0 (worst) to 30 (best).
Change in functional exercise capacity at 6 and 12 months compared with controls
The 1-minute Sit-to-Stand Test (1mSTS) measures the number of sit-to-stand transitions during 1 minute.
Change in Walking Speed at 6 and 12 months compared with controls
10 meter Walk Test (10mWT) assesses walking speed (m/s) over a short duration.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Majanka H. Heijenbrok-Kal, PhD
Lead sponsor
Erasmus Medical Center
Sponsor institution
Netherlands Brain Foundation
Collaborator